XellSmart

company

About

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

  • Minhang,Shanghai,China
  • 51 - 100

Details

Last Funding Type
Series A
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2021
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Shize Bio-Pharmaceutical (Shanghai) Co., Ltd.
Also Known As
士泽生物,Shize Biologics,Shize Bio-Pharmaceutical (Shanghai) Co

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥77M
XellSmart has raised a total of ¥77M in funding over 2 rounds. Their latest funding was raised on Sep 7, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 7, 2022 Series A 10 Xiamen Jinyuan Venture Capital
China Singapore Suzhou Industrial Park Ventures
Eli Lilly
Qiming Venture Partners
Detail
Sep 8, 2021 Seed ¥77M 7 Lilly Asia Ventures
Qiming Venture Partners
Sequoia Capital China
Detail

Employee Profiles

Number of Employee Profiles
1
XellSmart has 1 current employee profiles, including Executive Xiang Li
Executive